Compare SGHT & GORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHT | GORO |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.0M | 212.0M |
| IPO Year | 2021 | 2010 |
| Metric | SGHT | GORO |
|---|---|---|
| Price | $4.99 | $1.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $9.08 | $1.63 |
| AVG Volume (30 Days) | 188.2K | ★ 1.6M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 28.16 | ★ 91.80 |
| EPS | N/A | ★ 0.03 |
| Revenue | $77,363,000.00 | ★ $99,759,000.00 |
| Revenue This Year | $11.67 | $25.99 |
| Revenue Next Year | $10.39 | $5.78 |
| P/E Ratio | ★ N/A | $43.00 |
| Revenue Growth | N/A | ★ 51.78 |
| 52 Week Low | $3.11 | $0.43 |
| 52 Week High | $9.24 | $1.87 |
| Indicator | SGHT | GORO |
|---|---|---|
| Relative Strength Index (RSI) | 57.35 | 43.68 |
| Support Level | $4.86 | $1.27 |
| Resistance Level | $5.25 | $1.49 |
| Average True Range (ATR) | 0.40 | 0.09 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 57.24 | 33.33 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.